Document Detail

Signaling determinants of glioma cell invasion.
MedLine Citation:
PMID:  22879067     Owner:  NLM     Status:  In-Data-Review    
Tumor cell invasiveness is a critical challenge in the clinical management of glioma patients. In addition, there is accumulating evidence that current therapeutic modalities, including anti-angiogenic therapy and radiotherapy, can enhance glioma invasiveness. Glioma cell invasion is stimulated by both autocrine and paracrine factors that act on a large array of cell surface-bound receptors. Key signaling elements that mediate receptor-initiated signaling in the regulation of glioblastoma invasion are Rho family GTPases, including Rac, RhoA and Cdc42. These GTPases regulate cell morphology and actin dynamics and stimulate cell squeezing through the narrow extracellular spaces that are typical of the brain parenchyma. Transient attachment of cells to the extracellular matrix is also necessary for glioblastoma cell invasion. Interactions with extracellular matrix components are mediated by integrins that initiate diverse intracellular signalling pathways. Key signaling elements stimulated by integrins include PI3K, Akt, mTOR and MAP kinases. In order to detach from the tumor mass, glioma cells secrete proteolytic enzymes that cleave cell surface adhesion molecules, including CD44 and L1. Key proteases produced by glioma cells include uPA, ADAMs and MMPs. Increased understanding of the molecular mechanisms that control glioma cell invasion has led to the identification of molecular targets for therapeutic intervention in this devastating disease.
Aneta Kwiatkowska; Marc Symons
Related Documents :
17891177 - S-phase progression stimulates both the mutagenic ku-independent pathway and mutagenic ...
19795077 - Fluorodeoxyuridine mediated cell cycle synchronization in s-phase increases the auger r...
16049977 - Critical interval of somal calcium transient after neurite transection determines b 104...
12913157 - Constitutive e2f expression in tobacco plants exhibits altered cell cycle control and m...
19003087 - S-phase synchronized cho cells show elevated transfection efficiency and expression usi...
3872907 - Bcgfii activity on activated b cells of a purified murine t cell-replacing factor (trf)...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Advances in experimental medicine and biology     Volume:  986     ISSN:  0065-2598     ISO Abbreviation:  Adv. Exp. Med. Biol.     Publication Date:  2013  
Date Detail:
Created Date:  2012-08-10     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0121103     Medline TA:  Adv Exp Med Biol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  121-41     Citation Subset:  IM    
Center for Oncology and Cell Biology, Laboratory for Brain Tumor Biology, Feinstein Institute for Medical Research, 350 Community Dr, 11030, Manhasset, NY, USA,
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Cytoskeleton and nucleotide signaling in glioma c6 cells.
Next Document:  Receptor tyrosine kinases: principles and functions in glioma invasion.